Back to mobile site

Amgen (AMGN), Cytokinetics (CYTK) Announce COSMIC-HF Met Primary Endpoint

November 9, 2015 6:16 AM EST Send to a Friend
Amgen (Nasdaq: AMGN) and Cytokinetics Incorporated (Nasdaq: CYTK) announced the presentation of data from the expansion phase of COSMIC-HF (Chronic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login